Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $743.17M | $749.19M | $487.71M | $496.65M | $477.62M | $462.33M | $336.96M | $330.99M |
| Cost of revenue | $590.17M | $589.65M | $413.50M | $423.47M | $377.99M | $353.44M | $243.04M | $249.77M |
| Gross profit | $153.00M | $159.54M | $74.21M | $73.18M | $99.63M | $108.89M | $93.92M | $81.21M |
| Gross margin | 20.6% | 21.3% | 15.2% | 14.7% | 20.9% | 23.6% | 27.9% | 24.5% |
| Selling, general and administrative | $124.44M | $131.69M | $123.11M | $97.15M | $109.79M | $109.70M | $115.02M | $90.20M |
| Operating expenses | $125.00M | $132.21M | $123.53M | $97.55M | $110.19M | $110.16M | $115.37M | $90.00M |
| Operating income | $28.00M | $27.33M | −$49.32M | −$24.38M | −$10.56M | −$1.27M | −$21.45M | −$8.79M |
| Operating margin | 3.8% | 3.6% | -10.1% | -4.9% | -2.2% | -0.3% | -6.4% | -2.7% |
| EBITDA | $28.14M | $27.41M | −$49.40M | −$25.31M | −$10.67M | −$1.25M | −$21.49M | −$11.12M |
| Income before taxes | $28.00M | $27.33M | −$49.32M | −$24.38M | −$10.58M | −$1.27M | −$21.48M | −$8.79M |
| Net income | $28.00M | $27.33M | −$49.32M | −$24.38M | −$10.58M | −$1.27M | −$22.09M | −$9.16M |
| Net margin | 3.8% | 3.6% | -10.1% | -4.9% | -2.2% | -0.3% | -6.6% | -2.8% |
| EPS, basic | $0.05 | $0.05 | −$0.09 | −$0.05 | −$0.02 | $0.00 | −$0.04 | −$0.02 |
| EPS, diluted | $0.05 | $0.05 | −$0.09 | −$0.05 | −$0.02 | $0.00 | −$0.04 | −$0.02 |
| Diluted shares | 545.45M | 532.50M | 529.03M | 512.74M | 509.04M | 497.06M | 496.04M | 490.18M |
Figures describe Clover Health Investments shares, not any token. As of Aug 7, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.